| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |